TranspareRx Corporation, a leading healthcare technology company renowned for its innovative prescription savings platforms Cuverd and TextRx, has announced a strategic collaboration with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs). This partnership aims to revolutionize prescription affordability by integrating Cost Plus Drugs' transparent pricing into Cuverd and TextRx platforms. Through this integration, patients gain access to comprehensive pricing information, enabling them to compare direct discount pricing with insurance coverage seamlessly.
